Korea Revamps Drug Review Processes, Cuts Approval Timelines

 
• By Jung Won Shin

Under the new drug approval innovation measures, Korea will cut the review and approval period of new drugs to 295 days from 420 days and increase the number of expert reviewers to enhance review capabilities.

Korea Bolsters Drug Review Capabilities, Speeds Up Approval In Regulatory Innovation
Korea will Bolster its Drug Review Capabilities and Speed Approval times. • Source: Shutterstock

More from South Korea

More from Asia